Loading
Clinical Maestro
Clinical Maestro is an AI-driven, cloud-based SaaS platform developed by Strategikon Pharma, designed to enhance the management of clinical trial operations. Founded in 2017 and launched commercially in January 2019, the company is headquartered in San Rafael, California, and employs a team of approximately 36 to 38 people. The platform aims to reduce costs and expedite the time to market for new medical treatments through its comprehensive solutions. The Clinical Maestro platform automates clinical trial budgeting, vendor selection, and contract management. It features integrated modules for budgeting, vendor sourcing, contract management, governance, and bidding. The platform provides real-time insights and transparency, enabling better decision-making and operational efficiency. Clinical Maestro primarily serves biopharmaceutical companies, contract research organizations, and clinical service providers, offering significant savings and high accuracy in cost modeling for clinical trials.
Funding
Every round, secondary, debt facility or acquisition involving Clinical Maestro that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$4M